Use this calendar to find events organised or co-organised by the Milner Therapeutics Institute. If you have questions regarding any event in our calendar, please contact events@milner.cam.ac.uk.
.
The Cambridge Alliance on Medicines Safety (CAMS) is delighted to welcome Dr Chris Powell from GSK to talk about the important issue of safety studies needed to support clinical trials.
A Korean delegation of pharma, SMEs, and investment companies (including Chong Kun Dang Pharmaceuticals, SK Chemicals, Yuhan Corporation, Daewoong Pharmaceuticals Co Ltd, ShinPoong Pharm Co Ltd, Korea Investment Partners and SBI Investment) are visiting Cambridge in the hope of meeting UK biotech and pharma companies. Their aim is to identify opportunities for collaboration, investment or […]
A summit to explore the UK advantage in Cell and Gene Therapy How can joining up science and value in cell and gene therapy deliver global health impact? The summit will explore the journey from science to patients and what value means for different people and organisations. This half day event is for scientists, investors […]
An event (with free registration) to foster the In silico Toxicology Community in the UK and beyond. Scientific contributions are as welcome as those on ongoing work, regulatory aspects, industry perspectives, databases, relevant software, journals etc. in the field.
A new monthly seminar series starting in 2020 Talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. This week's speakers are James Nathan (CITIID) & Namshik Han (Milner).
This event will include talks and a networking lunch, followed by opportunities to arrange a 1:1 meeting with representatives from the Medicines Discovery Catapult (MDC). The MDC enables academics and SMEs involved in translational biomedical research to develop their therapeutic discovery projects and associated technologies.
Public Health@Cambridge Network and Hughes Hall are hosting a one day interdisciplinary conference bringing together current Cambridge research relevant to the processes and contexts of ageing.
In this event, representatives from Johnson & Johnson Innovation will provide an overview of goals and missions, highlighting how Johnson & Johnson Innovation interacts with the entrepreneurial community through JLABS, JJDC, The Innovation Centers and Janssen Business & Development. Following the presentation, the Johnson & Johnson Innovation team will meet one-on-one with early-stage companies and […]
A new monthly seminar series starting in 2020. Talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. This week's speakers are Ludovic Vallier (Wellcome MRC Cambridge Stem Cell Institute) & Pal Mander (GlaxoSmithKline)
This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and pioneering applications in therapeutic genome editing.
Will include presentations on a device to enhance fine motor skills, new ways to monitor blood glucose, and a spinal neurostimulation implant. Medical i-Teams investigate the best applications and routes to market for new university inventions, by interviewing relevant experts, clinicians and patient advocates.
The March meeting of the Cambridge New Therapeutics Forum (CamNTF) is now open for registration. This meeting will be hosted by the Cambridge Alliance on Medicines Safety and we are delighted to be holding this event at the newly-opened Jeffrey Cheah Biomedical Centre - home of The Milner Therapeutics Institute.
An interdisciplinary conference on the research, practice and education of global health. Keynote address by Dame Sally Davies. Organised by Cambridge Global Health Partnerships in collaboration with the PublicHealth@Cambridge Network at the Cambridge Institute of Public Health
The 2020 ELRIG Research & Innovation conference will discuss how the most promising new biology is being identified and explore emerging technologies and innovations to enable this science to be translated into successful therapeutics.
POSTPONED The organising committee for the C2D3 Research Symposium, 22 April 2020, have taken the decision to postpone the event due to Covid-19.
Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. Talks will be available online all day, with a live Q&A at 1pm. This week's speaker is Mathew Garnett, from the Wellcome Sanger Institute: "Functional genomics approaches to guide cancer drug discovery" You can now access Mathews's talk using the […]
A series of webinars covering the drug discovery process, from the experts at Medicines Discovery Catapult (MDC) and CRO network partners.
Biweekly talks from academics and industry scientists, highlighting advances in disease understanding and therapeutic approaches. Available now! The Talk: This talk is now live using the credentials below. Waradon Sungnak (Wellcome Sanger Institute) “Single-Cell Transcriptomics Analysis of SARS-CoV-2 Entry Factors” Click here » Password: 6c$0012^ The QA&: Thank you to everyone who joined in for our […]
Hosted by Dr Nicholas Matheson, CITIID PI and consultant in Infectious Diseases. Each episode includes an update on the evolving COVID-19 pandemic, and a review of the latest developments in SARS-CoV-2 biomedical research and experimental medicine.